Key result
Erythropoietin administration in uremic rats accentuated hypertension and renal injury, which was improved by the superoxide dismutase-mimetic tempol.
Why the study?
Does tempol improve erythropoietin-induced hypertension and renal injury in uremic rats?
Does tempol improve erythropoietin-induced hypertension and renal injury in uremic rats?
Oxidative stress plays a key role in EPO-induced hypertension and renal injury in uremia, which can be attenuated by antioxidant therapy with tempol.
Answers are grounded in this paper and cite their sources.
Oxidative stress may drive EPO-induced hypertension in uremia; leaves open whether antioxidants benefit patients.
Erythropoietin (EPO) administration in uremic rats leads to an increase in blood pressure (BP). Because chronic renal failure has been associated with oxidative stress, we hypothesize that EPO treatment could accentuate this condition and contribute to hypertension. The present study was designed to investigate the role of reactive oxygen species in EPO-induced hypertension and the effect of tempol, a superoxide dismutase-mimetic.Renal failure was induced by a two-stage 5/6 nephrectomy followed by a 3-week stabilization period. Uremic rats were divided into four groups and received for 4 weeks: vehicle; EPO (100 U/kg, subcutaneously, three times per week); vehicle + tempol (1 mmol/l in drinking water); and EPO + tempol. Systolic BP and biochemical parameters were assessed before and at the end of the treatment. Renal histology, creatinine clearance rate, endothelin-1 (ET-1) concentrations and superoxide anion production were assessed at the end of the study.The uremic rats developed anemia and hypertension. ET-1 concentrations and superoxide anion production were increased. EPO administration corrected anemia, but accentuated hypertension and renal injuries such as glomerulosclerosis, interstitial fibrosis, and inflammation. EPO therapy further increased tissue levels of ET-1 and superoxide anion production. Tempol treatment improved hypertension and renal injury, and reduced ET-1 concentrations and superoxide anion production.Oxidative stress contributes to the development of hypertension and to the progression of renal injuries in uremic rats. EPO administration further increases oxidative stress, which might partly account for the accentuation of hypertension and renal injury.
No takes yet. Share an insight, caveat, or question.
Rancourt et al. (2009) studied Uremia and EPO-induced hypertension. Erythropoietin (EPO) with or without tempol vs. Vehicle was evaluated on Systolic blood pressure, renal histology, creatinine clearance rate, ET-1 concentrations, and superoxide anion production. Erythropoietin administration in uremic rats accentuated hypertension and renal injury, which was improved by the superoxide dismutase-mimetic tempol.
Synapse has enriched 10 related papers. Consider them for comparative context: